BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19380367)

  • 1. The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue.
    Sano D; Choi S; Milas ZL; Zhou G; Galer CE; Su YW; Gule M; Zhao M; Zhu Z; Myers JN
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):411-20. PubMed ID: 19380367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivascular therapy of oral tongue squamous cell carcinoma with PTK787.
    Yazici YD; Kim S; Jasser SA; Wang Z; Carter KB; Bucana CD; Myers JN
    Laryngoscope; 2005 Dec; 115(12):2249-55. PubMed ID: 16369175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.
    Galer CE; Corey CL; Wang Z; Younes MN; Gomez-Rivera F; Jasser SA; Ludwig DL; El-Naggar AK; Weber RS; Myers JN
    Head Neck; 2011 Feb; 33(2):189-98. PubMed ID: 20848439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An orthotopic nude mouse model of oral tongue squamous cell carcinoma.
    Myers JN; Holsinger FC; Jasser SA; Bekele BN; Fidler IJ
    Clin Cancer Res; 2002 Jan; 8(1):293-8. PubMed ID: 11801572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases.
    Morelli MP; Cascone T; Troiani T; Tuccillo C; Bianco R; Normanno N; Romano M; Veneziani BM; Fontanini G; Eckhardt SG; De Pacido S; Tortora G; Ciardiello F
    J Cell Physiol; 2006 Aug; 208(2):344-53. PubMed ID: 16688779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
    van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
    Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cetuximab and bevacizumab therapy in a murine orthotopic model of anaplastic thyroid carcinoma.
    Prichard CN; Kim S; Yazici YD; Doan DD; Jasser SA; Mandal M; Myers JN
    Laryngoscope; 2007 Apr; 117(4):674-9. PubMed ID: 17429874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma.
    Knowles JA; Golden B; Yan L; Carroll WR; Helman EE; Rosenthal EL
    Laryngoscope; 2011 Nov; 121(11):2359-65. PubMed ID: 22020886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.
    Kim S; Prichard CN; Younes MN; Yazici YD; Jasser SA; Bekele BN; Myers JN
    Clin Cancer Res; 2006 Jan; 12(2):600-7. PubMed ID: 16428506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of neoadjuvant chemotherapy on metastasis of oral squamous cell carcinoma in a mouse model.
    Kawashiri S; Noguchi N; Tanaka A; Nakaya H; Kato K; Yamamoto E
    Oral Oncol; 2009 Sep; 45(9):794-7. PubMed ID: 19200774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cervical lymph node metastatic model of human tongue carcinoma: Serial and orthotopic transplantation of histologically intact patient specimens in nude mice.
    Qiu C; Wu H; He H; Qiu W
    J Oral Maxillofac Surg; 2003 Jun; 61(6):696-700. PubMed ID: 12796881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cetuximab inhibits growth, peritoneal dissemination, and lymph node and lung metastasis of endometrial cancer, and prolongs host survival.
    Takahashi K; Saga Y; Mizukami H; Takei Y; Machida S; Fujiwara H; Ozawa K; Suzuki M
    Int J Oncol; 2009 Oct; 35(4):725-9. PubMed ID: 19724908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.
    Sano D; Matsumoto F; Valdecanas DR; Zhao M; Molkentine DP; Takahashi Y; Hanna EY; Papadimitrakopoulou V; Heymach J; Milas L; Myers JN
    Clin Cancer Res; 2011 Apr; 17(7):1815-27. PubMed ID: 21350000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
    Bruns CJ; Shrader M; Harbison MT; Portera C; Solorzano CC; Jauch KW; Hicklin DJ; Radinsky R; Ellis LM
    Int J Cancer; 2002 Nov; 102(2):101-8. PubMed ID: 12385004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma.
    Knowles JA; Heath CH; Saini R; Umphrey H; Warram J; Hoyt K; Rosenthal EL
    Arch Otolaryngol Head Neck Surg; 2012 Jul; 138(7):662-8. PubMed ID: 22801891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cetuximab: from bench to bedside.
    Vincenzi B; Zoccoli A; Pantano F; Venditti O; Galluzzo S
    Curr Cancer Drug Targets; 2010 Feb; 10(1):80-95. PubMed ID: 20088790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model.
    Jung YD; Mansfield PF; Akagi M; Takeda A; Liu W; Bucana CD; Hicklin DJ; Ellis LM
    Eur J Cancer; 2002 May; 38(8):1133-40. PubMed ID: 12008203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.